Role of intestinal mucin-2 in the effectiveness of the treatment of Helicobacter spp . infection in laboratory mice

Abnormal synthesis of the main intestinal proteo­ glycan mucin­2 is typical of ulcerative colitis and Crohn’s disease in humans. Those morphological changes of the mucus layer affect the diversity of the intestinal microflora. Antibiotics may be ineffective or even dangerous to humans or animals deficient for mucin­2 because of the risk of sepsis and chronic inflammation. In this study, we investigated the potential of antibiotics (clarithromycin, amoxicillin, and metronidazole) in elimination of pathogenic infection from Muc2 knockout mice (Muc2–/–). We assayed the population sizes of pathogens (Heli­co­ bacter spp.) and symbiotic (E. coli­) bacteria in the intestines of animals as a criterion of antibiotic efficacy. The damaging effect of antibacterial treatment on the host body was estimated from their survival rate. Three antibiotics were ineffective in the elimination of Heli­cobacter spp. from mucin­2­deficient mice. Moreover, the mortality of Muc2 knockout mice during the antibacterial treatment was 60 %. The survival of wild­type mice (C57BL/6J) during the treatment was 100 %. The weight of wild­type mice showed no decrease during the treatment. The Heli­cobacter spp. pathogen was fully eradicated from wild­type mice. Thus, therapy of Heli­cobacter spp. infection in mucin­2 deficient animals is not only poorly efficient but even deadly. The high susceptibility to antibiotics allows Muc2 knockout mice to be used as a test model to evaluate the pharmacological safety of new antibiotics.

[1]  P. Adegboyega,et al.  Helicobacter infection decreases basal colon inflammation, but increases disease activity in experimental IBD , 2013 .

[2]  Gabriel Núñez,et al.  Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.

[3]  P. Adamski,et al.  Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis , 2013, BMC Gastroenterology.

[4]  Timothy L. Tickle,et al.  Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.

[5]  R. Vance,et al.  Lethal inflammasome activation by a multi-drug resistant pathobiont upon antibiotic disruption of the microbiota , 2012, Nature Medicine.

[6]  B. Finlay,et al.  Antibiotic Treatment Alters the Colonic Mucus Layer and Predisposes the Host to Exacerbated Citrobacter rodentium-Induced Colitis , 2011, Infection and Immunity.

[7]  N. Socci,et al.  Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. , 2010, The Journal of clinical investigation.

[8]  J. Watson,et al.  Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D. , 2010, Journal of the American Association for Laboratory Animal Science : JAALAS.

[9]  B. Finlay,et al.  Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa , 2010, PLoS pathogens.

[10]  M. Seidelin,et al.  FELASA guidelines for the accreditation of health monitoring programs and testing laboratories involved in health monitoring , 2010, Lab Animal.

[11]  Eric C. Martens,et al.  Complex Glycan Catabolism by the Human Gut Microbiota: The Bacteroidetes Sus-like Paradigm , 2009, The Journal of Biological Chemistry.

[12]  A. Velcich,et al.  The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria , 2008, Proceedings of the National Academy of Sciences.

[13]  L. Hale,et al.  Helicobacter infection decreases reproductive performance of IL10-deficient mice. , 2008, Comparative medicine.

[14]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[15]  J. Meijerink,et al.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. , 2006, Gastroenterology.

[16]  A. Kerton,et al.  Review of successful treatment for Helicobacter species in laboratory mice , 2006, Laboratory animals.

[17]  P. Rehbinder,et al.  Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units , 2002, Laboratory animals.

[18]  P. Desreumaux,et al.  Infectious agents and Crohn's disease. , 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  J. Fox,et al.  Helicobacter bilis/Helicobacter rodentium co-infection associated with diarrhea in a colony of scid mice. , 1998, Laboratory animal science.

[20]  P. Menon,et al.  Pathogenesis of diarrhea due to escherichia coli , 1980, Indian journal of pediatrics.